Síndrome HELLP

Martin JN Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 1):1500-9; discussion 1509-13. Resumen

Martin JN Jr, Brewer JM, Wallace K, et al. Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med. 2013 Aug;26(12):1201-6. Resumen

Martin JN Jr, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1373-84. Resumen

American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 222: gestational hypertension and preeclampsia. Jun 2020 [internet publication].Texto completo

Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003 Jul;102(1):181-92. Resumen

Martin JN Jr, Owens MY. Preeclampsia-eclampsia y syndrome de HELLP. In: Romero Arauz JF, Tena Alavez G, Jimenez Solis GA, eds. Preeclampsia - enfermedades hipertensivas del embarazo [in Spanish]. Mexico: McGraw Hill; 2012.

Sibai BL, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):125-9. Resumen

Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD004659.Texto completo  Resumen

Martin JN Jr, Owens MY, Keiser SD, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31(1):79-90. Resumen

Martin JN Jr. Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia). Int J Gynaecol Obstet. 2013 Jun;121(3):202-7. Resumen

Martin JN Jr, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005 Feb;105(2):246-54. Resumen

Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004 May;103(5 Pt 1):981-91. Resumen

O'Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol. 2005 Jun;48(2):460-77. Resumen

1. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol. 1993 Oct;169(4):1000-6. Resumen

2. Martin JN Jr, Blake PG, Perry KG Jr, et al. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol. 1991 Jun;164(6 Pt 1):1500-9; discussion 1509-13. Resumen

3. Martin JN Jr, Magann EF, Blake PG, et al. Severe preeclampsia/eclampsia with HELLP syndrome in 454 pregnancies: comparative analysis using the 3-class system of classification. 1993 SMFM meeting abstract. Am J Obstet Gynecol. 1993;168:386.

4. Martin JN Jr, Brewer JM, Wallace K, et al. Hellp syndrome and composite major maternal morbidity: importance of Mississippi classification system. J Matern Fetal Neonatal Med. 2013 Aug;26(12):1201-6. Resumen

5. Martin JN Jr, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999 Jun;180(6 Pt 1):1373-84. Resumen

6. Brewer JM, Martin JN Jr, Canizaro A, et al. HELLP syndrome(s) and severe preeclampsia differentiation according to maternal outcomes: class 1 HELLP syndrome trumps all others. Abstract 773: 2012 SMFM meeting, Dallas, Texas, February 2012. Amer J Obstet Gynecol 2012;206:S341.

7. Maged AM, Elsherief A, Hassan H, et al. Maternal, fetal, and neonatal outcomes among different types of hypertensive disorders associating pregnancy needing intensive care management. J Matern Fetal Neonatal Med. 2020 Jan;33(2):314-21. Resumen

8. American College of Obstetricians and Gynecologists. ACOG practice bulletin no. 222: gestational hypertension and preeclampsia. Jun 2020 [internet publication].Texto completo

9. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. BMC Pregnancy Childbirth. 2009 Feb 26;9:8.Texto completo  Resumen

10. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003 Jul;102(1):181-92. Resumen

11. Ducarme G, Bernuau J, Luton D, et al. Liver and preeclampsia [in French]. Ann Fr Anesth Reanim. 2010 Apr;29(4):e97-103. Resumen

12. Keiser SD, Owens MY, Parrish MR, et al. HELLP syndrome with and without eclampsia. Am J Perinatol. 2011 Mar;28(3):187-94. Resumen

13. Noubiap JJ, Bigna JJ, Nyaga UF, et al. The burden of hypertensive disorders of pregnancy in Africa: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2019 Apr;21(4):479-88.Texto completo  Resumen

14. Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, et al. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health. 2018;10:371-7.Texto completo  Resumen

15. Martin JN Jr, Owens MY. Preeclampsia-eclampsia y syndrome de HELLP. In: Romero Arauz JF, Tena Alavez G, Jimenez Solis GA, eds. Preeclampsia - enfermedades hipertensivas del embarazo [in Spanish]. Mexico: McGraw Hill; 2012.

16. Mentese A, Güven S, Demir S, et al. Circulating parameters of oxidative stress and hypoxia in normal pregnancy and HELLP syndrome. Adv Clin Exp Med. 2018 Nov;27(11):1567-72.Texto completo  Resumen

17. Bean C, Spencer SK, Pabbidi MR, et al. Peripheral anti-angiogenic imbalance during pregnancy impairs myogenic tone and increases cerebral edema in a rodent model of HELLP syndrome. Brain Sci. 2018 Dec 6;8(12):216.Texto completo  Resumen

18. Hanff E, Ruben S, Kreuzer M, et al. Development and validation of GC-MS methods for the comprehensive analysis of amino acids in plasma and urine and applications to the HELLP syndrome and pediatric kidney transplantation: evidence of altered methylation, transamidination, and arginase activity. Amino Acids. 2019 Mar;51(3):529-47. Resumen

19. Berryman K, Buhimschi CS, Zhao G, et al. Proteasome levels and activity in pregnancies complicated by severe preeclampsia and hemolysis, elevated liver enzymes, and thrombocytopenia (HELLP) syndrome. Hypertension. 2019 Jun;73(6):1308-18.Texto completo  Resumen

20. Stefanovic V. The Extended use of eculizumab in pregnancy and complement activation - associated diseases affecting maternal, fetal and neonatal kidneys - the future is now? J Clin Med. 2019 Mar 24;8(3):407.Texto completo  Resumen

21. Yonekura Collier AR, Zsengeller Z, Pernicone E, et al. Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia. Hypertens Pregnancy. 2019 Aug;38(3):193-9. Resumen

22. Wallace K, Harris S, Addison A, et al. HELLP syndrome: pathophysiology and current therapies. Curr Pharm Biotechnol. 2018;19(10):816-26. Resumen

23. Kawabata L, Nakai A, Takeshita T. Prediction of HELLP syndrome with assessment of maternal dual hepatic blood supply by using Doppler ultrasound. Arch Gynecol Obstet. 2006 Aug;274(5):303-9. Resumen

24. Darby M, Martin JN Jr, Mitchell SQ, et al. Liver bleeding in patients with HELLP syndrome: pathogenesis and implications for preventive therapy. Int J Gynaecol Obstet. 2013 Oct;123(1):7-9. Resumen

25. Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013 Feb;166(2):117-23. Resumen

26. Wallace K, Martin JN Jr, Tam Tam K, et al. Seeking the mechanism(s) of action for corticosteroids in HELLP syndrome: SMASH study. Am J Obstet Gynecol. 2013 May;208(5):380;e1-8. Resumen

27. Mihu D, Costin N, Mihu CM, et al. HELLP syndrome: a multisystemic disorder. J Gastrointestin Liver Dis. 2007 Dec;16(4):419-24. Resumen

28. Wallace K, Bean C, Bowles T, et al. Hypertension, anxiety, and blood-brain barrier permeability are increased in postpartum severe preeclampsia/hemolysis, elevated liver enzymes, and low platelet count syndrome rats. Hypertension. 2018 Oct;72(4):946-54.Texto completo  Resumen

29. Strand S, Strand D, Seufert R, et al. Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndrome. Gastroenterology. 2004 Mar;126(3):849-58.Texto completo  Resumen

30. Martin JN Jr, Rose CH, Briery CM. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol. 2006 Oct;195(4):914-34. Resumen

31. van Runnard Heimel PJ, Kavelaars A, Heijnen CJ, et al. HELLP syndrome is associated with an increased inflammatory response, which may be inhibited by administration of prednisolone. Hypertens Pregnancy. 2008;27(3):253-65. Resumen

32. Miranda ML, Macher HC, Muñoz-Hernández R, et al. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome. Am J Hypertens. 2013 Dec;26(12):1377-80.Texto completo  Resumen

33. Reimer T, Rohrmann H, Stubert J, et al. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis. J Matern Fetal Neonatal Med. 2013 Feb;26(3):263-9. Resumen

34. ACOG Committee on Clinical Consensus-Obstetrics, Society for Maternal-Fetal Medicine, Gantt A, et al. Obstetric care consensus no. 11, Pregnancy at age 35 years or older. Am J Obstet Gynecol. 2022 Jul 16;S0002-9378(22)00576-2.Texto completo  Resumen

35. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol. 1997 Nov;177(5):1003-10. Resumen

36. ACOG Committee on Clinical Practice Guidelines–Obstetrics. Headaches in pregnancy and postpartum: ACOG clinical practice guideline no. 3. Obstet Gynecol. 2022 May 1;139(5):944-72. Resumen

37. Aukes AM, Yurtsever FN, Boutin A, et al. Associations between migraine and adverse pregnancy outcomes: systematic review and meta-analysis. Obstet Gynecol Surv. 2019 Dec;74(12):738-48. Resumen

38. Facchinetti F, Allais G, Nappi RE, et al. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. Cephalalgia. 2009 Mar;29(3):286-92.Texto completo  Resumen

39. Sibai BL, Ramadan MK, Chari RS, et al. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):125-9. Resumen

40. Chames MC, Haddad B, Barton JR, et al. Subsequent pregnancy outcome in women with a history of HELLP syndrome at ≤ 28 weeks of gestation. Am J Obstet Gynecol. 2003 Jun;188(6):1504-7; discussion 1507-8. Resumen

41. van Pampus MG, Wolf H, Mayruhu G, et al. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy. 2001;20(1):15-23. Resumen

42. Habli M, Eftekhari N, Wiebracht E, et al. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol. 2009 Oct;201(4):385;e1-5. Resumen

43. US Preventive Services Task Force. Final recommendation statement: low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: preventive medication. Sep 2021 [internet publication].Texto completo

44. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 743: low-dose aspirin use during pregnancy. Jul 2018 [internet publication].Texto completo

45. Duley L, Meher S, Hunter KE, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD004659.Texto completo  Resumen

46. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. 25 June 2019 [internet publication].Texto completo

47. Sibai BM. Prevention of preeclampsia: a big disappointment. Am J Obstet Gynecol. 1998 Nov;179(5):1275-8. Resumen

48. Roberts JM, Myatt L, Spong CY, et al. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010 Apr 8;362(14):1282-91.Texto completo  Resumen

49. Rodger MA, Paidas M, McLintock C, et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol. 2008 Aug;112(2 Pt 1):320-4. Resumen

50. Martin JN Jr, Thigpen BD, Rose CH, et al. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol. 2003 Sep;189(3):830-4. Resumen

51. Martin JN Jr, Owens MY, Keiser SD, et al. Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity. Hypertens Pregnancy. 2012;31(1):79-90. Resumen

52. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol. 1990 Feb;162(2):311-6. Resumen

53. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol. 1982 Jan 15;142(2):159-67. Resumen

54. Tomsen TR. HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets) presenting as generalized malaise. Am J Obstet Gynecol. 1995 Jun;172(6):1876-8; discussion 1878-80. Resumen

55. Owens MY, Martin JN Jr, Wallace K, et al. Postpartum thrombotic microangiopathic syndrome. Transfus Apher Sci. 2013 Feb;48(1):51-7. Resumen

56. Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol. 2009 Jun;33(3):196-205. Resumen

57. Govindappagari S, Nguyen M, Gupta M, et al. Severe vitamin B12 deficiency in pregnancy mimicking HELLP syndrome. Case Rep Obstet Gynecol. 2019 Mar 25;2019:4325647.Texto completo  Resumen

58. Khangura RK, Williams N, Cooper S, et al. Babesiosis in pregnancy: an imitator of HELLP syndrome. AJP Rep. 2019 Apr;9(2):e147-52.Texto completo  Resumen

59. Sarkissian S, Khan Y, Farrell D, et al. Hemophagocytic lymphohistiocytosis in the setting of HELLP syndrome. Clin Case Rep. 2018 Dec;6(12):2466-70.Texto completo  Resumen

60. Castro MA, Fassett MJ, Reynolds TB, et al. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol. 1999 Aug;181(2):389-95. Resumen

61. Martin JN Jr, Bailey AP, Rehberg JF, et al. Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006. Am J Obstet Gynecol. 2008;199:98-104. Resumen

62. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006 May 4;354(18):1927-35. Resumen

63. Hebisch G, Bernasconi MT, Gmuer J, et al. Pregnancy-associated recurrent hemolytic uremic syndrome with fetal thrombotic vasculopathy in the placenta. Am J Obstet Gynecol. 2001 Nov;185(5):1265-6. Resumen

64. Egerman RS, Witlin AG, Friedman SA, et al. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in pregnancy: review of 11 cases. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):950-6. Resumen

65. Appenzeller S, Souza FH, Wagner Silva de Souza A, et al. HELLP syndrome and its relationship with antiphospholipid syndrome and antiphospholipid antibodies. Semin Arthritis Rheum. 2011 Dec;41(3):517-23. Resumen

66. Chien PF, Arnott N, Gordon A, et al. How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview. BJOG. 2000;107:196-208. Resumen

67. Martin JN Jr (ed). The 2015 compendium for HELLP syndrome: from bench to bedside. New York: Nova Science Publishers; 2015.

68. Martin JN Jr. Milestones in the quest for best management of patients with HELLP syndrome (microangiopathic hemolytic anemia, hepatic dysfunction, thrombocytopenia). Int J Gynaecol Obstet. 2013 Jun;121(3):202-7. Resumen

69. Martin JN Jr, Thigpen BD, Moore RC, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005 Feb;105(2):246-54. Resumen

70. Vigil-De Gracia P. Maternal deaths due to eclampsia and HELLP syndrome. Int J Gynaecol Obstet. 2009 Feb;104(2):90-4. Resumen

71. Nassar AH, Adra AM, Chakhtoura N, et al. Severe preeclampsia remote from term: labor induction or elective cesarean delivery? Am J Obstet Gynecol. 1998 Nov;179(5):1210-3. Resumen

72. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol. 2004 May;103(5 Pt 1):981-91. Resumen

73. Basaran A, Basaran M, Sen C. Choice of glucocorticoid in HELLP syndrome - dexamethasone versus betamethasone: revisiting the dilemma. J Matern Fetal Neonatal Med. 2012 Dec;25(12):2597-600. Resumen

74. Katz L, Amorim M, Souza JP, et al. COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome. Reprod Health. 2013 May 22;10:28.Texto completo  Resumen

75. Kanonge TI, Chamunyonga F, Zakazaka N, et al. Hepatic rupture from haematomas in patients with pre-eclampsia/eclampsia: a case series. Pan Afr Med J. 2018 Oct 4;31:86.Texto completo  Resumen

76. Horazeck C, Crockett CJ. Saved by the massive transfusion protocol: a case report of an obstetric patient with hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome and glisson capsule rupture. A A Pract. 2019 Jun 1;12(11):409-11. Resumen

77. Kaltofen T, Grabmeier J, Weissenbacher T, et al. Liver rupture in a 28-year-old primigravida with superimposed pre-eclampsia and hemolysis, elevated liver enzyme levels, and low platelet count syndrome. J Obstet Gynaecol Res. 2019 May;45(5):1066-70. Resumen

78. Morgan J, Della Torre M, Whelan AR, et al. A case of massive hepatic infarction in a patient with HELLP syndrome. AJP Rep. 2019 Jan;9(1):e84-7.Texto completo  Resumen

79. Marinaş MC, Mogoș G, Drăgușin RC, et al. Postpartum spontaneous subcapsular hepatic hematoma (SSHH) - conservative management. Case report and review of literature. Curr Health Sci J. 2018 Oct-Dec;44(4):387-91.Texto completo  Resumen

80. Ghorbanpour M, Makarchian HR, Yousefi B, et al. Conservative management of postpartum HELLP syndrome and intraparenchymal liver hematoma; a case report. Bull Emerg Trauma. 2019 Apr;7(2):196-8.Texto completo  Resumen

81. Pereira Herrera M, Oaks JB, Brensilver J. A case of acute pancreatitis in hemolysis, elevated liver enzymes, and low platelets syndrome. Cureus. 2018 Jun 25;10(6):e2877.Texto completo  Resumen

82. Takahashi A, Kita N, Tanaka Y, et al. Effects of high-dose dexamethasone in postpartum women with class 1 haemolysis, elevated liver enzymes and low platelets (HELLP) syndrome. J Obstet Gynaecol. 2019 Apr;39(3):335-9. Resumen

83. Vidaeff AC, Carroll MA, Ramin SM. Acute hypertensive emergencies in pregnancy. Crit Care Med. 2005 Oct;33(10 Suppl):S307-12. Resumen

84. Medicines and Healthcare products Regulatory Agency. Magnesium sulfate: risk of skeletal adverse effects in the neonate following prolonged or repeated use in pregnancy. 17 May 2019 [internet publication].Texto completo

85. Food and Drug Administration. FDA recommends against prolonged use of magnesium sulfate to stop pre-term labor due to bone changes in exposed babies. 30 May 2013 [internet publication].Texto completo

86. Sherwin CM, Balch A, Campbell SC, et al. Maternal magnesium sulphate exposure predicts neonatal magnesium blood concentrations. Basic Clin Pharmacol Toxicol. 2014 Apr;114(4):318-22.Texto completo  Resumen

87. Abbassi-Ghanavati M, Alexander JM, McIntire DD, et al. Neonatal effects of magnesium sulfate given to the mother. Am J Perinatol. 2012 Nov;29(10):795-9.Texto completo  Resumen

88. Das M, Chaudhuri PR, Mondal BC, et al. Assessment of serum magnesium levels and its outcome in neonates of eclamptic mothers treated with low-dose magnesium sulfate regimen. Indian J Pharmacol. 2015 Sep-Oct;47(5):502-8.Texto completo  Resumen

89. Jansen MA, Pluymen LP, Dalmeijer GW, et al. Hypertensive disorders of pregnancy and cardiometabolic outcomes in childhood: a systematic review. Eur J Prev Cardiol. 2019 Nov;26(16):1718-47.Texto completo  Resumen

90. American College of Obstetricians and Gynecologists. ACOG committee opinion no. 455: magnesium sulfate before anticipated preterm birth for neuroprotection. Mar 2010 [internet publication].Texto completo

91. Elatrous S, Nouira S, Ouanes Besbes L, et al. Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol. Intensive Care Med. 2002 Sep;28(9):1281-6. Resumen

92. Magee LA, Cham C, Waterman EJ, et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ. 2003 Oct 25;327(7421):955-60.Texto completo  Resumen

93. O'Brien JM, Barton JR. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol. 2005 Jun;48(2):460-77. Resumen

94. Fitzpatrick KE, Hinshaw K, Kurinczuk JJ, et al. Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome. Obstet Gynecol. 2014;123:618-27. Resumen

95. O'Kelly AC, Michos ED, Shufelt CL, et al. Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022 Feb 18;130(4):652-72.Texto completo  Resumen

96. Grandi SM, Filion KB, Yoon S, et al. Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019 Feb 19;139(8):1069-79.Texto completo  Resumen

97. Wenger NK, Lloyd-Jones DM, Elkind MSV, et al. Call to action for cardiovascular disease in women: epidemiology, awareness, access, and delivery of equitable health care: a presidential advisory from the American Heart Association. Circulation. 2022 Jun 7;145(23):e1059-71.Texto completo  Resumen

98. Yildirim G, Gungorduk K, Gul A, et al. HELLP syndrome: 8 years of experience from a tertiary referral center in western Turkey. Hypertens Pregnancy. 2012;31(3):316-26. Resumen

99. Drakeley AJ, Le Roux PA, Anthony J, et al. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol. 2002 Feb;186(2):253-6. Resumen

100. Sibai BM, Ramadan MK. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes, and low platelets. Am J Obstet Gynecol. 1993 Jun;168(6 Pt 1):1682-7; discussion 1687-90. Resumen

101. Jacquemyn Y, Jochens L, Duiker E, et al. Long-term renal function after HELLP syndrome. Gynecol Obstet Invest. 2004;57(2):117-20. Resumen

102. Ye W, Shu H, Yu Y, et al. Acute kidney injury in patients with HELLP syndrome. Int Urol Nephrol. 2019 Jul;51(7):1199-206. Resumen

103. Ye W, Shu H, Wen Y, et al. Renal histopathology of prolonged acute kidney injury in HELLP syndrome: a case series and literature review. Int Urol Nephrol. 2019 Jun;51(6):987-94. Resumen

104. Gilbert WM, Towner DR, Field NT, et al. The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia. Am J Obstet Gynecol. 2000 Jun;182(6):1397-403. Resumen

105. Rinehart BK, Terrone DA, Magann EF, et al. Preeclampsia-associated hepatic hemorrhage and rupture: mode of management related to maternal and perinatal outcome. Obstet Gynecol Surv. 1999 Mar;54(3):196-202. Resumen

106. Woods JB, Blake PG, Perry KG Jr, et al. Ascites: a portent of cardiopulmonary complications in the preeclamptic patient with the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol. 1992 Jul;80(1):87-91. Resumen

107. Haug EB, Horn J, Markovitz AR, et al. Life course trajectories of cardiovascular risk factors in women with and without hypertensive disorders in first pregnancy: the HUNT study in Norway. J Am Heart Assoc. 2018 Aug 7;7(15):e009250.Texto completo  Resumen

108. Stuart JJ, Tanz LJ, Cook NR, et al. Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction. J Am Coll Cardiol. 2018 Sep 11;72(11):1252-63.Texto completo  Resumen

109. Martin JN Jr, Files JC, Blake PG, et al. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol. 1995 Apr;172(4 Pt 1):1107-25; discussion 1125-7. Resumen

110. Knapen MF, van Altena AM, Peters WH, et al. Liver function following pregnancy complicated by the HELLP syndrome. Br J Obstet Gynecol. 1998 Nov;105(11):1208-10. Resumen